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ASSOCIATION BETWEEN PSYCHOSOCIAL FACTORS, QUALITY OF LIFE AND 
ATRIAL FIBRILLATION 
 
Summer Aldrugh1, Mayank Sardana2, Darleen M. Lessard3, Jane S. Saczynski3, David 
D. McManus2 
1Department of Medicine, 2Division of Cardiovascular Medicine, 3Division of 
Epidemiology, Department of Quantitative Health Sciences, University of Massachusetts 
Medical School 
 
Background: Atrial fibrillation (AF) is associated with cognitive and psychosocial 
comorbidities, and poorer quality of life (QOL). In this study, we aimed to study the 
association between cognition, psychosocial status and QOL at baseline and AF 
recurrence.  
 
Methods: We enrolled 222 symptomatic AF patients (64±10.0 years, 36% women) 
treated with a rhythm-control strategy. We performed cognitive, psychosocial, and QOL 
assessments using Montreal cognitive assessment (MOCA, cognitive impairment <26), 
generalized anxiety disorder assessment (GAD; anxiety ≥5), patient health 
questionnaire-9 (PHQ-9, depression≥5), and the AF Effect on QualiTy- of- Life (AFEQT) 
questionnaire respectively. AF recurrences were assessed for 6 months from the 
enrollment using validated methods from patient self-report and health record review. 
Multivariable logistic regression models were used to examine associations between 
cognition, anxiety, depression, and QOL at baseline with AF recurrence, adjusting for 
age, sex, and AF treatment type (catheter ablation vs. pharmacotherapy).  
 
Results: A total of 123 (55%) participants experienced an AF recurrence over the 6-
month follow-up period. Participants with an AF recurrence had higher rates of 
depression (31% vs.14%, p=0.022) and lower QOL (62±24 vs. 72±21, p=0.003) at 
baseline than did participants free from recurrence. In multivariable logistic regression 
models, lower baseline QOL, but not depression, anxiety, or cognition, was associated 
with a significantly higher odds of AF recurrence event (Odds Ratio: 0.98, CI 0.97-0.99).  
 
Conclusion: Lower AF-related QOL is associated with higher odds of AF recurrence 
over 6 months among symptomatic AF patients treated with rhythm control. Patient-
reported variables have not previously been considered as risk factors for disease 
progression or prognosis. Our data suggests QOL may serve as a useful tool to aid 
clinicians in the management of AF patients. 
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